Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-026692

EVP and Chief Medical Officer acquired 4,658 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Crombez Eric EVP and Chief Medical Officer 2023-05-01 Grant or award +4,658 30,512 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Crombez Eric EVP and Chief Medical Officer 2023-05-01 Grant or award · Stock Option (Right to Buy) +8,362 8,362 D: show line 2 in the form
Loading xslF345X04/doc4.xml…